# Remiges BioPharma Fund, LP — Form D/A

Remiges BioPharma Fund, LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2017-03-09. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2017-03-09
- Form: D/A
- Accession: 0001609623-17-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $80.0M
- Amount sold: $80.0M
- Investors: 4
- Date of first sale: 2014-06-06
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-218532

## Issuer

- Name: Remiges BioPharma Fund, LP
- CIK: 0001609623
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2014
- Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: (617) 401-2136

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Taro Inaba | Director | TOKYO, M0 |
| Walter Olesiak | Director | New York, NY |
| Walter Olesiak | Executive Officer | New York, NY |
| N/A REMIGES BIOPHARMA FUND GP, INC. | Executive Officer | CAMBRIDGE, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-07-08](https://search.stillhousedata.com/formd/0001609623-14-000003) | D/A | $150.0M | $70.0M |
| [2014-06-04](https://search.stillhousedata.com/formd/0001609623-14-000002) | D | $150.0M | — |

## More

- [CIK 1609623 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1609623&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001609623-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.